GLP-1 receptor agonists like semaglutide act on brain centers that control hunger, satiety, and food preferencenot just appetite suppression
People with chronic kidney disease, due to reduced kidney functions and reduced excretion 8
The researchers looked at health data for 145,410 patients living in Denmark, Sweden and Norway who were prescribed GLP-1 medications like semaglutidethe generic name for Ozempic, Wegovy and Rybelsusand liraglutidethe generic name for Saxenda and Victozaand another 291,667 patients who were treated with DPP4 inhibitors, another type of diabetes drug
Retatrutide is generating more legitimate scientific interest than almost anything else in the weight loss and metabolic health space right now
Not only does this establish a new theoretical basis for applying PLB in PCOS treatment, but it also paves the way for investigating RNA modification mechanisms in metabolic diseases
The majority of reports of nausea, vomiting, and/or diarrhea occurred during dose escalation and decreased over time
